|
|
DSpace at RU >
Search Results
Results 1-50 of 114.
Item hits:
| Full Text | Issue Date | Title | Author(s) |  | 2011 | Differences in T cell depletion and intestinal mucositis explain inconsistent effects of NOD2/CARD15 polymophisms in SCT | Velden, W.J.F.M. van der; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2011 | EUCAST Technical note on Amphotericin B. | Lass-Florl, C.; Arendrup, M.C.; Rodriguez-Tudela, J.L.; Cuenca-Estrella, M.; Donnelly, P.; Hope, W. |
| | 2011 | Issues in genetic association studies: limitations of statistical analysis and biological plausibility | Velden, W.J.F.M. van der; Feuth, T.; Stevens, W.B.C.; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2011 | Detecteren van koorts bij de hematologische patiënt in de neutropene fase. [Detection of fever in the neutropenic period of the haematological patient] | Ploos van Amstel, F.K.; Vliet, M. van; Potting, C.M.J.; Donnelly, P.; Blijlevens, N.M.A.; Schoonhoven, L. |
| | 2011 | Integrated array of 2-mum antimonide-based single-photon counting devices | Diagne, M.A.; Greszik, M.; Duerr, E.K.; Zayhowski, J.J.; Manfra, M.J.; Bailey, R.J.; Donnelly, J.P.; Turner, G.W. |
| | 2011 | EUCAST technical note on posaconazole | Arendrup, M.C.; Cuenca-Estrella, M.; Donnelly, J.P.; Hope, W.; Lass-Florl, C.; Rodriguez-Tudela, J.L. |
| | 2011 | EUCAST technical note on anidulafungin | Arendrup, M.C.; Rodriguez-Tudela, J.L.; Lass-Florl, C.; Cuenca-Estrella, M.; Donnelly, J.P.; Hope, W. |
| | 2011 | Reliability, Sensitivity, and Specificity of the VA Traumatic Brain Injury Screening Tool | Donnelly, K.T.; Donnelly, J.P.; Dunnam, M.; Warner, G.C.; Kittleson, C.J.; Constance, J.E.; Bradshaw, C.B.; Alt, M. |
| | 2011 | European expert opinion on the management of invasive candidiasis in adults | Kullberg, B.J.; Verweij, P.E.; Akova, M.; Arendrup, M.C.; Bille, J.; Calandra, T.; Cuenca-Estrella, M.; Herbrecht, R.; Jacobs, F.; Kalin, M.; Kibbler, C.C.; Lortholary, O.; Martino, P.; Meis, J.F.; Munoz, P.; Odds, F.C.; Pauw, B.E. de; Rex, J.H.; Roilides, E.; Rogers, T.R.; Ruhnke, M.; Ullmann, A.J.; Uzun, O.; Vandewoude, K.; Vincent, J.L.; Donnelly, J.P. |
| | 2011 | Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy | Lunel, F.M.; Donnelly, J.P.; Lee, H.A.L. van der; Blijlevens, N.M.A.; Verweij, P.E. |
| | 2011 | Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens | White, P.L.; Mengoli, C.; Bretagne, S.; Cuenca-Estrella, M.; Finnstrom, N.; Klingspor, L.; Melchers, W.J.G.; McCulloch, E.; Barnes, R.A.; Donnelly, J.P.; Loeffler, J. |
| | 2011 | Antifungal prophylaxis during treatment for haematological malignancies: are we there yet? | Rogers, T.R.; Slavin, M.A.; Donnelly, J.P. |
 | 2011 | How prompt is prompt in daily practice? Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient | Vliet, M. van; Potting, C.M.J.; Sturm, P.D.J.; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2011 | Genetic variants and the risk for invasive mould disease in immunocompromised hematology patients | Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Donnelly, J.P. |
| | 2011 | The Y238X stop codon polymorphism in the human beta-glucan receptor dectin-1 and susceptibility to invasive aspergillosis | Chai, L.; Boer, M.G. de; Velden, W.J. van der; Plantinga, T.S.; Spriel, A.B. van; Jacobs, C.W.; Halkes, C.J.; Vonk, A.G.; Blijlevens, N.M.A.; Dissel, J.T. van; Donnelly, P.; Kullberg, B.J.; Maertens, J.; Netea, M.G. |
| | 2011 | 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours | Aapro, M.S.; Bohlius, J.; Cameron, D.A.; Dal Lago, L.; Donnelly, J.P.; Kearney, N.; Lyman, G.H.; Pettengell, R.; Tjan-Heijnen, V.C.; Walewski, J.; Weber, D.C.; Zielinski, C. |
| | 2011 | Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease | Cornely, O.A.; Maertens, J.; Bresnik, M.; Ebrahimi, R.; Dellow, E.; Herbrecht, R.; Donnelly, J.P. |
| | 2011 | A two-stage meta-analysis identifies several new loci for Parkinson's disease. | Plagnol, V.; Nalls, M.A.; Bras, J.M.; Hernandez, D.; Sharma, M.; Sheerin, U.M.; Saad, M.; Simon-Sanchez, J.; Schulte, C.; Lesage, S.; Sveinbjornsdottir, S.; Amouyel, P.; Arepalli, S.; Band, G.; Barker, R.A.; Bellinguez, C.; Ben-Shlomo, Y.; Berendse, H.W.; Berg, D.; Bhatia, K.P.; Bie, R.M. de; Biffi, A.; Bloem, B.R.; Bochdanovits, Z.; Bonin, M.; Brockmann, K.; Brooks, J.; Burn, D.J.; Charlesworth, G.; Chen, H.; Chinnery, P.F.; Chong, S.; Clarke, C.E.; Cookson, M.R.; Cooper, J.M.; Corvol, J.C.; Counsell, J.; Damier, P.; Dartigues, J.F.; Deloukas, P.; Deuschl, G.; Dexter, D.T.; Dijk, K.D. van; Dillman, A.; Durif, F.; Durr, A.; Edkins, S.; Evans, J.R.; Foltynie, T.; Freeman, C.; Gao, J.; Gardner, M.; Gibbs, J.R.; Goate, A.; Gray, E.; Guerreiro, R.; Gustafsson, O.; Harris, C.; Hellenthal, G.; Hilten, J.J. van; Hofman, A.; Hollenbeck, A.; Holton, J.L.; Hu, M.; Huang, X.; Huber, H.; Hudson, G.; Hunt, S.E.; Huttenlocher, J.; Illig, T.; Jonsson, P.V.; Langford, C.; Lees, A.J.; Lichtner, P.; Limousin, P.; Lopez, G.; McNeill, A.; Moorby, C.; Moore, M.; Morris, H.A.; Morrison, K.E.; Mudanohwo, E.; O'Sullivan, S.S; Pearson, J.; Pearson, R.; Perlmutter, J.; Petursson, H.; Pirinen, M.; Polnak, P.; Post, B.; Potter, S.C.; Ravina, B.; Revesz, T.; Riess, O.; Rivadeneira, F.; Rizzu, P.; Ryten, M.; Sawcer, S.J.; Schapira, A.; Scheffer, H.; Shaw, K.; Shoulson, I.; Sidransky, E.; Silva, R. de; Smith, C.; Spencer, C.C.; Stefansson, H.; Steinberg, S.; Stockton, J.D.; Strange, A.; Su, Z.; Talbot, K.; Tanner, C.M.; Tashakkori-Ghanbaria, A.; Tison, F.; Trabzuni, D.; Traynor, B.J.; Uitterlinden, A.G.; Vandrovcova, J.; Velseboer, D.; Vidailhet, M.; Vukcevic, D.; Walker, R.; Warrenburg, B.P.C. van de; Weale, M.E.; Wickremaratchi, M.; Williams, N.; Williams-Gray, C.H.; Winder-Rhodes, S.; Stefansson, K.; Martinez, M.; Donnelly, P.; Singleton, A.B.; Hardy, J.; Heutink, P.; Brice, A.; Gasser, T.; Wood, N.W. |
 | 2010 | Galactomannan detection and diagnosis of invasive aspergillosis. | Donnelly, J.P.; Leeflang, M.M. |
| | 2010 | Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. | White, P.L.; Perry, M.D.; Loeffler, J.; Melchers, W.J.G.; Klingspor, L.; Bretagne, S.; McCulloch, E.; Cuenca-Estrella, M.; Finnstrom, N.; Donnelly, J.P.; Barnes, R.A. |
| | 2010 | EUCAST breakpoints for antifungals. | Rodriguez-Tudela, J.L.; Arendrup, M.C.; Cuenca-Estrella, M.; Donnelly, J.P.; Lass-Florl, C. |
| | 2010 | Host-microbe interactions in stem cell transplantation: recognizing Candida in infection and inflammation. | Velden, W.J.F.M. van der; Plantinga, T.S.; Donnelly, J.P.; Kullberg, B.J.; Blijlevens, N.M.A.; Netea, M.G. |
| | 2010 | The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status. | Velden, W.J.F.M. van der; Plantinga, T.S.; Feuth, T.; Donnelly, J.P.; Netea, M.G.; Blijlevens, N.M.A. |
| | 2010 | Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. | Herbers, A.H.E.; Feuth, T.; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2010 | Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. | Velden, W.J.F.M. van der; Herbers, A.H.E.; Feuth, T.; Schaap, N.P.M.; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2010 | Aspergillus PCR: one step closer to standardization. | White, P.L.; Bretagne, S.; Klingspor, L.; Melchers, W.J.G.; McCulloch, E.; Schulz, B.; Finnstrom, N.; Mengoli, C.; Barnes, R.A.; Donnelly, J.P.; Loeffler, J. |
| | 2010 | Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients. | Bruggemann, R.J.M.; Blijlevens, N.M.A.; Burger, D.M.; Franke, B.; Troke, P.F.; Donnelly, J.P. |
| | 2010 | A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. | Strange, A.; Capon, F.; Spencer, C.C.; Knight, J.; Weale, M.E.; Allen, M.H.; Barton, A.; Band, G.; Bellenguez, C.; Bergboer, J.G.M.; Blackwell, J.M.; Bramon, E.; Bumpstead, S.J.; Casas, J.P.; Cork, M.J.; Corvin, A.; Deloukas, P.; Dilthey, A.; Duncanson, A.; Edkins, S.; Estivill, X.; Fitzgerald, O.; Freeman, C.; Giardina, E.; Gray, E.; Hofer, A.; Huffmeier, U.; Hunt, S.E.; Irvine, A.D.; Jankowski, J.; Kirby, B.; Langford, C.; Lascorz, J.; Leman, J.; Leslie, S.; Mallbris, L.; Markus, H.S.; Mathew, C.G.; McLean, W.H.I.; McManus, R.; Mossner, R.; Moutsianas, L.; Naluai, A.T.; Nestle, F.O.; Novelli, G.; Onoufriadis, A.; Palmer, C.N.; Perricone, C.; Pirinen, M.; Plomin, R.; Potter, S.C.; Pujol, R.M.; Rautanen, A.; Riveira-Munoz, E.; Ryan, A.W.; Salmhofer, W.; Samuelsson, L.; Sawcer, S.J.; Schalkwijk, J.; Smith, C.H.; Stahle, M.; Su, Z.; Tazi-Ahnini, R.; Traupe, H.; Viswanathan, A.C.; Warren, R.B.; Weger, W.; Wolk, K.; Wood, N.; Worthington, J.; Young, H.S.; Zeeuwen, P.L.J.M.; Hayday, A.; Burden, A.D.; Griffiths, C.E.; Kere, J.; Reis, A.; McVean, G.; Evans, D.M.; Brown, M.A.; Barker, J.N.; Peltonen, L.; Donnelly, P.; Trembath, R.C. |
| | 2009 | Timely intervention for invasive fungal disease: should the road now lead to the laboratory instead of the pharmacy? | Pauw, B.E. de; Donnelly, J.P. |
| | 2009 | Safe living after hematopoietic cell transplantation. | Yokoe, D.; Casper, C.; Dubberke, E.; Lee, G.; Munoz, P.; Palmore, T.; Sepkowitz, K.; Young, J.A.; Donnelly, J.P. |
| | 2009 | Association of fluconazole pharmacodynamics with mortality in patients with candidemia. | Arendrup, M.C.; Cuenca-Estrella, M.; Donnelly, J.P.; Lass-Florl, C.; Rodriguez-Tudela, J.L. |
| | 2009 | Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. | Yokoe, D.; Casper, C.; Dubberke, E.; Lee, G.; Munoz, P.; Palmore, T.; Sepkowitz, K.; Young, J.A.; Donnelly, J.P. |
| | 2009 | Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy. | Lunel, F.M.; Mennink-Kersten, M.A.S.H.; Ruegebrink, D.; Lee, H.A.L. van der; Donnelly, J.P.; Blijlevens, N.M.A.; Verweij, P.E. |
| | 2009 | Breakpoints for susceptibility testing should not divide wild-type distributions of important target species. | Arendrup, M.C.; Kahlmeter, G.; Rodriguez-Tudela, J.L.; Donnelly, J.P. |
| | 2009 | A review of quality assessment of the methodology used in guidelines and systematic reviews on oral mucositis. | Potting, C.M.J.; Mistiaen, P.; Poot, E.; Blijlevens, N.M.A.; Donnelly, P.; Achterberg, T. van |
| | 2009 | Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11). | Velden, W.J.F.M. van der; Iersel, T.M. van; Blijlevens, N.M.A.; Donnelly, J.P. |
| | 2009 | Febrile mucositis in haematopoietic SCT recipients. | Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Feuth, A.B.; Donnelly, J.P. |
| | 2009 | Plasma citrulline measurement using UPLC tandem mass-spectrometry to determine small intestinal enterocyte pathology. | Demacker, P.N.M.; Beijers, A.M.; Daal, H. van; Donnelly, J.P.; Blijlevens, N.M.A.; Ouweland, J.M.W. van den |
| | 2009 | Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. | Derikx, J.P.; Blijlevens, N.M.A.; Donnelly, J.P.; Fujii, H.; Kanda, T.; Bijnen, A.A. van; Heineman, E.; Buurman, W.A. |
| | 2009 | Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy. | Verduyn Lunel, F.M.; Donnelly, J.P.; Lee, H.A.L. van der; Blijlevens, N.M.A.; Verweij, P.E. |
| | 2009 | Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. | Mengoli, C.; Cruciani, M.; Barnes, R.A.; Loeffler, J.; Donnelly, J.P. |
| | 2009 | NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. | Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Maas, F.M.H.M.; Schaap, N.P.M.; Jansen, J.H.; Reijden, B.A. van der; Feuth, A.B.; Dolstra, H.; Donnelly, J.P. |
| | 2009 | Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. | Plantinga, T.S.; Velden, W.J.F.M. van der; Ferwerda, E.B.; Spriel, A.B. van; Adema, G.J.; Feuth, A.B.; Donnelly, J.P.; Brown, G.D.; Kullberg, B.J.; Blijlevens, N.M.A.; Netea, M.G. |
| | 2008 | Invasieve zygomycose bij patiënten die worden behandeld voor een hematologische maligniteit | Verweij, P.E.; Velden, W.J.F.M. van der; Donnelly, P.; Blijlevens, N.M.A.; Warris, A. |
| | 2008 | EUCAST technical note on fluconazole | Rodriquez Tudela, J.L.; Donnelly, J.P.; Arendrup, M.C.; Arikan, S.; Barchiesi, F.; Bille, J.; Chryssanthou, E.; Cuenca-Estrella, M.; Dannaoui, E.; Denning, D.W.; Fegeler, W.; Gaustad, P.; Klimko, N.; Lass-Florl, C.; Moore, C.; Richardson, M.; Schmalreck, A.; Stenderup, J.; Velegraki, A.; Verweij, P.E. |
| | 2008 | EUCAST Technical Note on voriconazole. | Rodriguez-Tudela, J.L.; Donnelly, J.P.; Arendrup, M.C.; Arikan, S.; Barchiesi, F.; Bille, J.; Chryssanthou, E.; Cuenca-Estrella, M.; Dannaoui, E.; Denning, D.W.; Fegeler, W.; Gaustad, P.; Lass-Florl, C.; Moore, C.; Richardson, M.; Schmalreck, A.; Velegraki, J.A.; Verweij, P.E. |
| | 2008 | EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. | Rodriquez Tudela, J.L.; Donnelly, J.P.; Arendrup, M.C.; Arikan, S.; Barchiesi, F.; Bille, J.; Chryssanthou, E.; Cuenca-Estrella, M.; Dannaoui, E.; Denning, D.W.; Fegeler, W.; Gaustad, P.; Lass-Florl, C.; Moore, C.; Richardson, M.; Schmalreck, A.; Velegraki, J.A.; Verweij, P.E. |
| | 2008 | Human platelets attenuate Aspergillus species via granule-dependent mechanisms. | Perkhofer, S.; Kehrel, B.E.; Dierich, M.P.; Donnelly, J.P.; Nussbaumer, W.; Hofmann, J.; Eiff, C von; Lass-Florl, C. |
| | 2008 | Providing oral care in haematological oncology patients: nurses' knowledge and skills. | Potting, C.M.J.; Mank, A.; Blijlevens, N.M.A.; Donnelly, J.P.; Achterberg, T. van |
| | 2008 | Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients. | Herbers, A.H.E.; Blijlevens, N.M.A.; Donnelly, J.P.; Witte, T.J.M. de |
1
2
3
next
|
